Thanks Surges and ABDM - this should be a lot clearer for those...

Thanks Surges and ABDM - this should be a lot clearer for those concerned.

'OBJ has taken the decision to UNDERTAKE SOME OF THE PRELIMINARY TESTING (in vitro and in vivo) internally and provide the results to the targeted companies with which OBJ intends partnering.'

5 million is sound cash-on-hand for OBJ and I'm sure that any Phase 1,2, or 3 Pharmaceutical testing of partnering companies molecules or peptides for example, will be born at the expense of the partnering companies. Preliminary Testing is the key phrase here!

It's helpful for me as well, to thrash these issues out on forums like HC to keep a balanced perspective.

Cheers